In The Spotlight
DDNews Cancer Research Exclusive
Recent work with nanoparticles offers a new approach to photo-thermal cancer therapies
(Photo credit: University of Toronto)
The PEARLs (Photothermal Enhancing Auto-Regulated Liposomes) were developed by Dr. Gang Zheng of the Princess Margaret Cancer Centre and University of Toronto and colleagues, who say they overcome traditional roadblocks to penetrate deeper into tumors.
Companies extend global collaboration deal aimed at discovering Probody therapeutics for the treatment of cancer and other diseases
twoXAR announces preclinical proof-of-concept data on novel liver cancer candidate
Exclusive global deal revolves around immuno-oncology therapeutic leads that modulate the CD47-SIRPα pathway
A collection of recent regulatory approvals and other actions globally
Boehringer Ingelheim launches Phase 2 combo trial of afatinib in combination with pembrolizumab for patients with SqCC of the lung
Results from Diffusion’s Phase 1/2 trial of trans sodium crocetinate published in Journal of Neurosurgery
Phase 2 MONOCLE trial commences for orphan drug intended to treat chronic myelomonocytic leukemia
Nuclear localization of protein can change course of prostate cancer therapy
DDNews checks in on the growing and promising activity around immuno-oncology
by Dr. Brad Thompson, Oncolytics
During these heady and still-early days in the age of clinical studies involving immunotherapy, it is useful to ponder some of the outstanding questions these studies raise

by Laurie Heilmann
As the design of anticancer agents has evolved, the processes, methods and equipment used to aid the fight against cancer have too, leading to the resurgence of immunotherapy as a powerful way of fighting cancer

by Mike Nolan, Thermo Fisher
Next-generation sequencing is leading the way in providing a cost-effective and scalable approach to detect oncology driver mutations in solid tumor samples.

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.